February 9, 2015 — Cleveland Clinic and AliveCor, Inc. announced the online publication of study results from Cleveland ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
January 29, 2015 — St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility ...
The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 12, 2015 — Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ...
January 12, 2015 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial ...
January 12, 2015 — Medtronic Inc. announced the initiation of a randomized clinical trial in Europe to assess the ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
As editor of DAIC, I keep a close watch on trends in cardiovascular technology and try to predict what the next big ...
December 22, 2014 — AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have ...
December 19, 2014 — The American College of Cardiology’s recently released Guideline Clinical App has expanded with the ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
December 18, 2014 — Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New ...
December 8, 2014 — Researchers at the Minneapolis Heart Institute Foundation have found that when care teams started ...
December 4, 2014 — Medi?Lynx Cardiac Monitoring LLC and MEDICALgorithmics will participate in a research project ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...
November 24, 2014 — Obesity is a known risk factor for atrial fibrillation (AFib), the most common heart rhythm disorder ...
Nov. 5, 2014 — Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S ...